|
|
Kolon Life Science Inc
KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/28/2026 14:45
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization507,261 mln
Earnings Date08/18/2025
Key Fundamentals
EPS2,251
P/E6.96
ROE7.71
RPS15,404
ROIC4.35
ROA4.53
Interest Cover5.23
EBITDA, mln53,210
EV / EBITDA12.12
EV / EBIT14.94
Revenue, mln213,806
EV / Revenue3.02
Financial Strength
Altman Z-Score0.94
Piotroski F-Score
6
/ 9
Beneish M-Score-2.31
Price to Intrinsic Value1.52
Price to Graham Number0.88
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-26.16% |
1
/ 100
 |
| 1 Month |
-62.46% |
0
/ 100
|
| 2 Months |
-73.59% |
1
/ 100
|
| 6 Months |
-67.94% |
2
/ 100
|
| 1 Year |
-55.42% |
10
/ 100
 |
|
| |
